Overview

François Kress brings a rare blend of scientific expertise, drawn from his studies and years in biotechnology, as well as 25 years of experience in the luxury sector. This unique hybrid experience ideally positions him to introduce new biotechnologies to the market in a sophisticated way. A graduate of École Polytechnique and the Corps des Ponts et Chaussées, he possesses a strong scientific background. This, combined with his 25 years of leadership at renowned luxury companies such as LVMH, Bulgari, Prada, The Row, Stuart Weitzmann, and Carolina Herrera, enables him to effectively bridge the gap between cutting-edge biotechnologies and sophisticated market strategies.

In 2017, he co-founded and became CEO of two entities: Apex Neuro Holdings group and Feelmore Labs, a company that develops innovative consumer and clinical neuromodulation technologies, and actively and effortlessly enhances human well-being with scientifically proven results. His role at Apex Neuro Holdings and on the boards of companies such as Kythera Biopharmaceuticals (sold to Allergan for $2.1B in 2015) illustrates this synergy between luxury, health, and technology, fostering both technological advancements and their market introduction.